PolyPid Ltd
NASDAQ:PYPD
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.4
4.01
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
PolyPid Ltd
Free Cash Flow
PolyPid Ltd
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
PolyPid Ltd
NASDAQ:PYPD
|
Free Cash Flow
-$22m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-24%
|
|
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Free Cash Flow
$578m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-20%
|
|
|
Sol Gel Technologies Ltd
NASDAQ:SLGL
|
Free Cash Flow
-$5.7m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
I
|
InterCure Ltd
TASE:INCR
|
Free Cash Flow
-₪71.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-45%
|
|
|
Mediwound Ltd
NASDAQ:MDWD
|
Free Cash Flow
-$18.6m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
0%
|
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Free Cash Flow
₪14.6m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
PolyPid Ltd
Glance View
PolyPid Ltd. is a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes. The firm focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
See Also
What is PolyPid Ltd's Free Cash Flow?
Free Cash Flow
-22m
USD
Based on the financial report for Dec 31, 2024, PolyPid Ltd's Free Cash Flow amounts to -22m USD.
What is PolyPid Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-24%
Over the last year, the Free Cash Flow growth was -26%. The average annual Free Cash Flow growth rates for PolyPid Ltd have been 14% over the past three years , -4% over the past five years , and -24% over the past ten years .